Letters to the Editor
Efficacy of anifrolumab as a first-line therapy for the treatment of thrombocytopenia in systemic lupus erythematosus: a case report
F. Bottazzi1, E. Manna2, V. Codullo3, G. Zanframundo4, C. Montecuccco5, L. Cavagna6
- Department of Internal Medicine and Therapeutics, University of Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. francesca.bottazzi01@gmail.com
- Department of Internal Medicine and Therapeutics, University of Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Department of Internal Medicine and Therapeutics, University of Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Department of Internal Medicine and Therapeutics, University of Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Department of Internal Medicine and Therapeutics, University of Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Department of Internal Medicine and Therapeutics, University of Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
CER18377
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 40153335 [PubMed]
Received: 25/11/2024
Accepted : 23/12/2024
In Press: 20/03/2025